Murphy & Mullick Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.7K Buy
539
+26
+5% +$2K 0.03% 317
2025
Q4
$40.7K Sell
513
-86
-14% -$6.78K 0.03% 322
2025
Q3
$45.2K Sell
599
-631
-51% -$43.2K 0.03% 291
2025
Q2
$76.7K Sell
1,230
-156
-11% -$10.2K 0.06% 215
2025
Q1
$93.9K Sell
1,386
-10
-0.7% -$598 0.09% 182
2024
Q4
$62.7K Buy
+1,396
New +$78.3K 0.06% 230

Other funds holding CVS

Murphy & Mullick Capital Management's CVS Position: Q1 2026 in Review

Murphy & Mullick Capital Management increased its CVS Health (CVS) stake by 5.1% in Q1 2026, buying an estimated $2K and bringing the position to 539 shares worth $38.7K. The position accounts for 0.03% of the portfolio, ranked #317.

Murphy & Mullick Capital Management first reported a position in CVS in Q4 2024 and has held it in 6 quarters since. The position peaked at $93.9K in Q1 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Murphy & Mullick Capital Management held 539 shares of CVS Health worth $38.7K as of Q1 2026.
  • Murphy & Mullick Capital Management bought 26 CVS Health shares in Q1 2026, an estimated $2K.
  • CVS Health made up 0.03% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #317 holding.
  • Murphy & Mullick Capital Management first reported a position in CVS Health in Q4 2024 and has held it in 6 quarters since.
  • Murphy & Mullick Capital Management's CVS Health position peaked at $93.9K in Q1 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.